 | Up a level |
Goossens, N; de Vito, C; Mangia, A; Clément, S; Cenderello, G; Barrera, F; D'Ambrosio, R; Coppola, N; Zampino, R; Stanzione, M; Adinolfi, L E; Wedemeyer, H; Semmo, Nasser; Müllhaupt, B; Semela, D; Malinverni, R; Moradpour, D; Heim, M; Trincucci, G; Rubbia-Brandt, L; ... (2018). Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review. Journal of viral hepatitis, 25(8), pp. 920-929. Blackwell Science 10.1111/jvh.12891
Keiser, O; Giudici, F; Müllhaupt, B; Junker, C; Dufour, J-F; Moradpour, D; Bruggmann, P; Terziroli, B; Semela, D; Brezzi, M; Bertisch, B; Estill, J; Negro, F; Spoerri, A (2018). Trends in hepatitis C-related mortality in Switzerland. Journal of viral hepatitis, 25(2), pp. 152-160. Blackwell Science 10.1111/jvh.12803
Giudici, F; Bertisch, B; Negro, F; Stirnimann, G; Müllhaupt, B; Moradpour, D; Cerny, A; Dufour, Jean-François; Keiser, O (2016). Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person-centred approach. Journal of viral hepatitis, 23(9), pp. 697-707. Blackwell Science 10.1111/jvh.12535
Rüeger, S; Bochud, P-Y; Dufour, Jean-François; Müllhaupt, B; Semela, D; Heim, M H; Moradpour, D; Cerny, A; Malinverni, R; Booth, D R; Suppiah, V; George, J; Argiro, L; Halfon, P; Bourlière, M; Talal, A H; Jacobson, I M; Patin, E; Nalpas, B; Poynard, T; ... (2014). Impact of common risk factors of fibrosis progression in chronic hepatitis C. Gut, 64(10), pp. 1605-1615. BMJ Publishing Group 10.1136/gutjnl-2014-306997
Lange, CM; Kutalik, Z; Morikawa, K; Bibert, S; Cerny, A; Dollenmaier, G; Dufour, Jean-François; Gerlach, TJ; Heim, MH; Malinverni, R; Müllhaupt, B; Negro, F; Moradpour, D; Bochud, PY (2011). the Swiss Hepatitis C Cohort Study Group. Hepatology Hoboken, N.J.: Wiley Interscience
Overbeck, K; Dufour, Jean-François; Müllhaupt, B; Helbling, B; Borovicka, J; Malinverni, R; Heim, M; Moradpur, D; Cerny, A; Rickenbach, M; Negro, F (2010). Impact of international consensus guidelines on atniviral therapy of chronic hepatitis C patients in Switzerland. Swiss medical weekly Muttenz: EMH Schweizerischer Ärzteverlag
Sgier, C; Müllhaupt, B; Gerlach, T; Moradpour, D; Negro, F; Malé, PJ; Heim, MH; Malinverni, R; Cerny, A (2010). Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C. Journal of viral hepatitis, 17(12), pp. 845-850. Oxford: Blackwell Science 10.1111/j.1365-2893.2009.01251.x
Dinges, S; Morard, I; Heim, M; Dufour, Jean-François; Müllhaupt, B; Giostra, E; Clavien, P-A; Mentha, G; Negro, F (2009). Pegylated interferon-alpha2a/ribavirin treatment of recurrent hepatitis C after liver transplantation. Transplant infectious disease, 11(1), pp. 33-9. Hoboken, N.J.: Wiley 10.1111/j.1399-3062.2008.00359.x
Müller, NJ; Furrer, H; Kaiser, L; Hirschel, B; Cavassini, M; Fellay, J; Chave, JP; Wüthrich, RP; Weber, M; Müllhaupt, B; Candinas, D; Reichen, J; Giostra, E; Mentha, G; Halkic, N; Hirsch, HH; Weber, R; Swiss, HIV Cohort Study (2006). HIV and solid organ transplantation: the Swiss experience. Swiss medical weekly, 136(11-12), pp. 194-6. Muttenz: EMH Schweizerischer Ärzteverlag
Helbling, B; Jochum, W; Stamenic, I; Knöpfli, M; Cerny, A; Borovicka, J; Gonvers, JJ; Wilhelmi, M; Dinges, S; Müllhaupt, B; Esteban, A; Meyer-Wyss, B; Renner, EL; Swiss, Association for the Study of the Liver (SASL) (2006). HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirin. Journal of viral hepatitis, 13(11), pp. 762-9. Oxford: Blackwell Science 10.1111/j.1365-2893.2006.00753.x
Goossens, N; Coppola, N; Zampino, R; Stanzione, M; Wedemeyer, H; Barrera, F; Müllhaupt, B; Moradpour, D; Semela, D; Semmo, Nasser; Malinverni, R; Heim, M; George, J; Manns, M; Adinolfi, LE; Rubbia-Brandt, L; Negro, F (April 2014). The Effect of Hepatitis B Virus Infection on Steatosis in Hepatitis C Virus Coinfected Patients: The Bostic Study. In: EASL International Liver Congress 2014. London, UK. 09.-13.04.2014.
